The goal of this study was to explore the safety and efficacy of hyperbaric oxygen in the treatment of peripheral neuropathy due to paclitaxel analogues
Patients with newly diagnosed breast cancer by pathology
Age 18-60 years
ECOG 0-2
CIPN patients with NCI-CTCAE grade 1 or higher after treatment with paclitaxel-based drugs
Patients with contraindications to hyperbaric oxygen i. Untreated pneumothorax. ii. concomitant administration of disulfiram. iii. concomitant administration of antineoplastic drugs such as bleomycin, cisplatin, adriamycin. iv. premature and/or low body mass newborns.
Other cancers